FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073661 [Registered on: 09/09/2024] Trial Registered Prospectively
Last Modified On: 22/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Evaluating the effect of Jeeraka Avaleha in patients with Raktapradara and compare its efficacy with Pushyanuga Churna 
Scientific Title of Study   A Comparative Clinical Study to Evaluate the Efficacy of Jeeraka Avaleha in Raktapradara  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Saniya Mahammedsab Sanadi 
Designation  PG Scholar 
Affiliation  Alvas Ayurveda Medical College and Hospital Moodubidire  
Address  Department of P.G Studies in Prasuti Tantra Evam Stree Roga, Alvas Ayurveda Medical College and Hospital Moodubidire

Dakshina Kannada
KARNATAKA
574227
India 
Phone  8217896126  
Fax    
Email  saniyasanadi@yahoo.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kavitha B K  
Designation  Associate Professor  
Affiliation  Alvas Ayurveda Medical College and Hospital Moodubidire 
Address  Department of P.G Studies in Prasuti Tantra Evam Stree Roga, Alvas Ayurveda Medical College and Hospital Moodubidire

Dakshina Kannada
KARNATAKA
574227
India 
Phone  9008979169  
Fax    
Email  drkavithapradeep@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Saniya Mahammedsab Sanadi 
Designation  PG Scholar 
Affiliation  Alvas Ayurveda Medical College and Hospital Moodubidire 
Address  Department of P.G Studies in Prasuti Tantra Evam Stree Roga, Alvas Ayurveda Medical College and Hospital Moodubidire

Dakshina Kannada
KARNATAKA
574227
India 
Phone  8217896126  
Fax    
Email  saniyasanadi@yahoo.in  
 
Source of Monetary or Material Support  
Alvas Ayurveda Medical College and Hospital Moodubidire, Dakshina Kannada, Karnataka 574227 
 
Primary Sponsor  
Name  Dr Saniya Mahammedsab Sanadi 
Address  Department of P.G Studies in Prasuti Tantra Evam Stree Roga, Alvas Ayurveda Medical College and Hospital Moodubidire, Dakshina Kannada, Karnataka 574227 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Saniya Mahammedsab Sanadi  Alvas Ayurveda Medical College and Hospital Moodubidire  Department of P.G Studies in Prasuti Tantra Evam Stree Roga, Alvas Ayurveda Medical College and Hospital Moodubidire, Dakshina Kannada, Karnataka 574227
Dakshina Kannada
KARNATAKA 
08217896126

saniyasanadi@yahoo.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Alvas Ayurveda Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N921||Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Pushyanuga Churna, Reference: Charak Samhita Chikitsa Stana, Chapter 30 Yonivyapadchikitsa, Shloka no 90-95 , Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 8 Days, anupAna/sahapAna: Yes(details: Madhu (Sahapana) and Tandulodaka), Additional Information: Drug is administered from 4th day of menstrual cycle for 8 days for 2 consecutive cycles
2Intervention ArmDrugClassical(1) Medicine Name: Jeeraka Avaleha, Reference: Yogatarangini of Trimalla Bhatta, Chapter 74 Pradara, Shloka no 3-6 , Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 24(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 8 Days, anupAna/sahapAna: Yes(details: 150ml Ksheera/ Sukoshna Jala), Additional Information: Drug is administered from 4th day of menstrual cycle for 8 days for 2 consecutive cycles.
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1)Patients fulfilling diagnostic criteria
2)Patients will be selected in the age group of 15 to 45 years.
3)Patient with Hb more than 8-gram percent
4)Both married and unmarried women
5)Patient having excessive bleeding/prolonged bleeding/intermenstrual bleeding with the history of minimum of 2 cycles.
 
 
ExclusionCriteria 
Details  1)Patient with the history of bleeding disorders, DM, HTN, TB.
2)Endocrinal disorders like Thyroid Dysfunction, PCOS.
3)IUCD, OCP
4)Any benign or malignant growth in reproductive tract.
5)PID, Endometriosis, Adenomyosis, Uterine Fibroids, Uterine polyp.
6)If any Anatomical defects.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The effect of treatment will be assessed on the
basis of subjective criteria
1.Anruthau Alpam Api- Intermenstrual Scanty Bleeding
2.Vedana – Pain
objective criteria
1) Duration of menstrual flow
2) Amount of menstrual flow (Pictorial blood loss assessment)
3) Interval between cycles 
Assessment will be done on 4th day, 7th day and 11th day of the cycle during the period of treatment for 2 consecutive cycles. 
 
Secondary Outcome  
Outcome  TimePoints 
after treatment assessment will be done on the
basis of
a) subjective criteria:
i)Intermenstrual Bleeding
ii)Pain during menstruation
b) Objective Criteria-
i)Duration of menstrual flow
ii)Amount of menstrual flow (Pictorial blood loss assessment)
iii)Interval between cycles 
After treatment assessment will be done on 4th day of 3rd cycle. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Among the gynecological disorders, Raktapradara is frequent complaint and the incidence has become higher with degree of civilization. If this condition is not treated, it will lead to complications like infertility, anemia, endometrial malignancy. According to modern, hormonal methods are the first line in medical management. Unfortunately, many options can be associated with hormonal side effects, prevention of fertility and lack of efficacy, leading to discontinuation and progression to surgical interventions. Thus, to avoid it Jeeraka Avaleha in Yogatarangini, Pradara Adhyaya has been mentioned as   excellent medicine in Raktapradara It has drugs which contain Stambana, Artavajanana, Shulahara, Angamarda Prashamana, Pandugna etc  properties. It also has the drugs whose phytochemicals show anti-inflammatory, anti-oxidant, analgesic, antispasmodic action and can also be easily palatable. therefore an attempt is made to study the clinical evaluation of Jeeraka Avaleha in the management of raktapradara and compare its efficacy with the Pushyanuga choorna.

 

 
Close